Cross-cutting Evaluation – HIV across a lifetime

In 2022, 2.5 million children and adolescents aged 10-19 were living with HIV, representing about 6% of all people living with HIV (PLHIV). However, this age group proportionately remains the most affected by new infections and AIDS related deaths. At the same time, the issue of ageing with HIV is emerging: thanks to antiretroviral therapy (ART), people living with HIV are now living longer and nearly 4 million of them are over the age of 50. This is a population group which has received only little attention so far in the pandemic responses.

This summary presents the results of a cross-cutting evaluation of six projects funded by L’Initiative that aim to support specific population groups at each stage of life to respond to HIV: from childhood and adolescence to the transition to adulthood and older age. These projects were implemented between 2020 and 2025 in seven countries in Africa and one in Asia. The evaluation provided key lessons on adapting healthcare, psychosocial services, and advocacy to the specific needs of each age group.